RxDoctor Payments Data

Shari Shaltout

Nurse Practitioner · Ventnor City, NJNPI 1619622560

Payments from drug & device makers

$2,124in general payments, 2019–2025

Across 90 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$432
  • Madrigal Pharmaceuticals$231
  • Novo Nordisk$215
  • Amneal Pharmaceuticals LLC$162
  • Xeris Pharmaceuticals, Inc.$157
  • Lilly USA, LLC$152
  • plus $775 from 12 others

What the payments were for

  • Food & beverage$2,124100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,124 in reported general payments places this provider in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide110$207,615
MounjaroTirzepatide83$133,049
TrulicityDulaglutide54$94,530
JardianceEmpagliflozin65$87,037
FarxigaDapagliflozin Propanediol71$78,015
Tresiba Flextouch U-100Insulin Degludec73$55,579
Tresiba Flextouch U-200Insulin Degludec49$51,699
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog29$34,976
Fiasp FlextouchInsulin Aspart (Niacinamide)26$31,775
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/718$31,505
JanuviaSitagliptin Phosphate20$29,670
Soliqua 100-33Insulin Glargine/Lixisenatide19$29,169
FiaspInsulin Aspart (Niacinamide)17$23,197
Cinacalcet Hcl29$20,365
Janumet XrSitagliptin Phos/Metformin Hcl23$18,911

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$152$233,577148 claims
Novo NordiskOzempic, Fiasp$215$230,813127 claims
Boehringer IngelheimJardiance$17$87,03765 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$41$29,16919 claims
AbbVieSynthroid, Armour Thyroid$122$6,79061 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$162$4,889190 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Ventnor City

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →